Skip to content

HydroSoft Helical 100304H2HS-V-A2Recalls & reported problems

Microvention, Inc. · V-Trak · Class 2 · Implant

All models of HydroSoft Helical (21)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00816777021403), received between Feb 6, 2026 and Feb 6, 2026 — classified as 1 malfunction.

The most frequently reported specific device problem is “Premature Separation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Premature Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 6, 2026Premature Separation

    AS REPORTED: DR. WAS TREATING A RUPTURED PICA ANEURYSM ON THE RIGHT. A COIL EMBOLIZATION WAS PLANNED AS THE TREATMENT. AFTER PLACING SEVERAL MV COILS, A HYDROSOFT 3-4 WAS CHOSEN. THE COIL HAD TO BE REPOSITIONED IN THE ANEURYSM. WHEN DR. TRIED TO REMOVE THE COIL FROM THE ANEURYSM, IT PREMATURELY DETACHED. THERE WAS ONLY ONE LOOP REMAINING IN THE ANEURYSM. DR. WAS ABLE TO REMOVE THE COIL FROM THE ANEURYSM AND PATIENT BODY BY PULLING BACK THE MICROCATHETER. COIL AND MICROCATHETER WERE REMOVED FROM THE PATIENT BODY COMPLETELY. THE COIL WAS EXCHANGED TO A HYDROSOFT OF SAME SIZE AND THE EXAMINATION COMPLETED. THE PATIENT IS DOING WELL. NO INJURY CAUSED BY THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24283737 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page